Nutex Health (NASDAQ:NUTX) Hits New 52-Week High – Here’s What Happened

Nutex Health Inc. (NASDAQ:NUTX)’s share price reached a new 52-week high on Tuesday . The stock traded as high as $193.07 and last traded at $189.8350, with a volume of 124524 shares changing hands. The stock had previously closed at $183.88.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on NUTX. Wall Street Zen upgraded shares of Nutex Health from a “buy” rating to a “strong-buy” rating in a research report on Friday, November 28th. Weiss Ratings reissued a “hold (c)” rating on shares of Nutex Health in a research report on Monday, December 22nd. Two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, Nutex Health currently has an average rating of “Moderate Buy” and a consensus target price of $252.50.

Nutex Health Stock Up 2.6%

The firm’s 50-day moving average price is $139.71 and its 200-day moving average price is $115.14. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.20 and a quick ratio of 3.18. The company has a market cap of $1.33 billion, a price-to-earnings ratio of 10.16 and a beta of -0.03.

Nutex Health (NASDAQ:NUTX) last issued its earnings results on Tuesday, November 18th. The company reported $7.76 earnings per share for the quarter, topping the consensus estimate of ($5.43) by $13.19. The company had revenue of $243.99 million during the quarter, compared to the consensus estimate of $221.93 million. Nutex Health had a return on equity of 37.44% and a net margin of 11.62%.

Insiders Place Their Bets

In other news, CFO Jon Christian Bates purchased 750 shares of the company’s stock in a transaction that occurred on Tuesday, November 25th. The shares were purchased at an average price of $136.71 per share, with a total value of $102,532.50. Following the purchase, the chief financial officer directly owned 5,638 shares of the company’s stock, valued at approximately $770,770.98. This represents a 15.34% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 36.92% of the company’s stock.

Institutional Investors Weigh In On Nutex Health

Several large investors have recently added to or reduced their stakes in NUTX. Bank of America Corp DE increased its stake in shares of Nutex Health by 6,590.3% in the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock worth $66,000 after purchasing an additional 2,043 shares during the period. OMERS ADMINISTRATION Corp grew its holdings in Nutex Health by 28.8% in the 1st quarter. OMERS ADMINISTRATION Corp now owns 9,400 shares of the company’s stock valued at $442,000 after buying an additional 2,100 shares during the last quarter. Goldman Sachs Group Inc. increased its position in Nutex Health by 17.9% in the 1st quarter. Goldman Sachs Group Inc. now owns 18,119 shares of the company’s stock worth $852,000 after buying an additional 2,748 shares during the period. Jane Street Group LLC acquired a new position in shares of Nutex Health during the first quarter worth approximately $522,000. Finally, One Plus One Wealth Management LLC grew its stake in shares of Nutex Health by 3.3% in the second quarter. One Plus One Wealth Management LLC now owns 38,791 shares of the company’s stock worth $4,829,000 after acquiring an additional 1,250 shares during the last quarter. 5.32% of the stock is owned by institutional investors and hedge funds.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.